Drug-induced bullous lichenoid eruption: a side effect of nivolumab triggered by the TLR agonist imiquimod.

Autor: Costedoat I; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France., Vergara R; Pathological Department, CHU Bordeaux, Avenue du Haut Leveque, F-33600 Pessac, France., Dousset L; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France, INSERM U-1035, Univ. Bordeaux, F-33000 Bordeaux, France., Gerard E; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France., Prey S; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France, INSERM U-1035, Univ. Bordeaux, F-33000 Bordeaux, France., Dutriaux C; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France., Beylot-Barry M; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France, INSERM U-1035, Univ. Bordeaux, F-33000 Bordeaux, France., Pham-Ledard A; Dermatology Department, CHU Bordeaux, 1 av. Jean Burguet F-33000 Bordeaux, France, INSERM U-1053, Bordeaux Research in Translational Oncology team 3 Oncogenesis of cutaneous lymphomas, Univ. Bordeaux, F-33076 Bordeaux, France.
Jazyk: angličtina
Zdroj: European journal of dermatology : EJD [Eur J Dermatol] 2021 Feb 01; Vol. 31 (1), pp. 91-92.
DOI: 10.1684/ejd.2020.3951
Databáze: MEDLINE
Externí odkaz: